Patents Assigned to H2RC Corporation
  • Methods for inhibiting cancer and scar formation
    Patent number: 7468355
    Abstract: Methods for inhibiting cancer, scar formation, disrupting the cellular cytoskeleton, and conferring resistance from infection are disclosed. Such methods comprise the administration of oleuropein and/or the products of its hydrolysis in therapeutically effective amounts. To that end, a variety of pharmaceutical formulations and routes or administration are disclosed and may be utilized to treat a wide variety of diseases.
    Type: Grant
    Filed: November 13, 2003
    Date of Patent: December 23, 2008
    Assignee: H2RC Corporation
    Inventors: Hamdi K. Hamdi, Raquel Castellon